Betahistine Dihydrochloride 倍他司丁二盐酸盐
CAS 5579-84-0 MFCD00012813
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Analytical St
- {SNA} Analytical Standards, Analytical/Chromatography, Chromatography, Pharmaceutical Standards, Pharmacopeia Standards, USP Standards, USP Standards A - B
- {SNA} Analytical Standards, EP Standards, EP Standards A - B, Pharmacopeia & Metrological Institutes Standards, 分析/色谱
- {SNA} Analytical Standards, Analytical/Chromatography, Chromatography, EP Standards, EP Standards A - B, Pharmaceutical Standards, Pharmacopeia Standards
- {SNA} Analytical Standards, Chromatography, EP Standards, EP Standards A - B, Pharmaceutical Standards,
- {SNA} Building Blocks, C8, Chemical Synthesis,
相关文献及参考
- [2]. Gbahou F, et al. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.J Pharmacol Exp Ther. 2010 Sep 1;334(3):945-54.
- [3]. Tang KT, et al. Betahistine attenuates murine collagen-induced arthritis by suppressing both inflammatory and Th17 cell responses.Int Immunopharmacol. 2016 Oct;39:236-245.
- [1]. Poyurovsky M, et al. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients. Int Clin Psychopharmacol. 2005 Mar;20(2):101-3.
- [1]. Poyurovsky M, et al. The effect of betahistine, a histamine H1 receptor agonist/H3 antagonist, on olanzapine-induced weight gain in first-episode schizophrenia patients. Int Clin Psychopharmacol. 2005 Mar;20(2):101-3.
- [2]. Gbahou F, et al. Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism
安全信息
- S24/25 Avoid contact with skin and eyes 避免皮肤和眼睛接触;
GHS Symbol
- P261 Avoid breathing dust/fume/gas/mist/vapours/spray. 避免吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
- P262 Do not get in eyes, on skin, or on clothing. 不要接触眼睛,皮肤或衣服。
- P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
- P271 Use only outdoors or in a well-ventilated area.? 只能在室外或通风良好的地方使用。
- P273 Avoid release to the environment. 避免释放到环境中。
- P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
- P302+P352
- P304+P340
- P305+P351+P338
- P312 Call a POISON CENTER or doctor/physician if you feel unwell. 如果你感觉不适,呼叫解毒中心或医生/医师。
- P321 Specific treatment (see … on this label). 具体治疗(见本标签上的)。
- P332+P313
- P337+P313
- P362 Take off contaminated clothing and wash before reuse. 脱掉污染的衣服,清洗后方可重新使用
- P403+P233
- P405 Store locked up. 上锁保管。
- P501 Dispose of contents/container to..… 处理内容物/容器.....
- H315 Causes skin irritation 会刺激皮肤
- H319 Causes serious eye irritation 严重刺激眼睛
- H335 May cause respiratory irritation 可能导致呼吸道刺激
- H413 Maycauselonglastingharmfuleffectstoaquaticlife 可能对水生生物造成长期持续有害影响。
其他信息
- MOL 文件:5579-84-0.mol
- 用途一:用于治疗内耳眩晕症(即美尼尔综合症)、脑动脉硬化、脑供血不足以及高血压引起的眩晕、呕吐与耳鸣。
- 盐酸倍他司汀价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2010/06/21 167990010 盐酸倍他司汀 2-(2-(Methylamino)ethyl)pyridine dihydrochloride 99% 1 GR 278元 2010/06/21 167990250 盐酸倍他司汀 2-(2-(Methylamino)ethyl)pyridine dihydrochloride 99% 25 GR 2984元 2010/06/21 167990050 盐酸倍他司汀 2-(2-(Methylamino)ethyl)pyridine dihydrochloride 99% 5 GR 755元
- 组胺类扩张血管药物:盐酸倍他司汀又称抗眩宁、培他啶,为组胺H1受体激动剂,属组胺类扩张血管药物,具有扩张毛细血管,改善微循环作用,能增加脑血流量及内耳血流量,能松弛内耳毛细血管前括约肌,可消除内耳性眩晕、耳鸣和耳闭塞感。主要用于治疗梅尼埃病(一种特发性内耳疾病),急、慢性缺血性脑血管疾病,也用于治疗脑动脉硬化、缺血性脑血管病、头部外伤或高血压所致直立性眩晕、头昏、耳鸣、耳聋、内耳眩晕症等,对多种原因的头痛均有缓解作用,对褥疮也有明显疗效。 倍他司汀盐酸盐对毛细血管的扩张作用与组胺相似,但不增加其通透性,能显著增加脑和内耳血流量,消除内淋巴水肿,直接抑制前庭神经核多触突Ⅰ型神经元产生的大量冲动,从而消除梅尼埃综合征的眩晕、耳鸣和耳闭等症状。该药也有轻微的抗凝血、抗血小板聚集、降低血液黏滞度和利尿作用。
- Sigma Aldrich:5579-84-0(sigmaaldrich)
- Acros Organics:N-甲基-2-吡啶乙胺二盐酸盐 2-(2-(Methylamino)ethyl)pyridine dihydrochloride, 99%(5579-84-0)
- MSDS 信息:2-(2-(Methylamino)ethyl)pyridine dihydrochloride(5579-84-0).msds